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Objective: During systemic inflammation,
elevated levels of endothelin (ET)-1 have
been reported. The aim of this study was
to investigate the effects of ET-1 on
neutrophil (PMN) respiratory burst,
phagocytosis, and elimination of
Escherichia coli from blood and tissues.
Design: Prospective, randomized,
controlled trial.
Setting: Experimental laboratory in a
university hospital.
Subjects: A total of 18 female chinchilla
rabbits.
Interventions: To quantify the clearance
process, defined numbers (108 colony-
forming units) of E. coli were injected
intravenously into anesthetized rabbits,
60 mins after onset of continuous 0.2
g/kg/min ET-1 administration (n = 9) and
after saline infusion (control group, n = 9),
respectively. To evaluate potential effects
of ET-1 on bacterial elimination and
killing, blood clearance of E. coli and
colonization of different organs were
investigated.
Measurements: Variables monitored were
neutrophil respiratory burst and
phagocytosis activity, rates of bacterial
elimination from the blood, arterial blood
pressure, blood gases, serum lactate
concentrations, and nitrite and nitrate
levels. The animals were killed 3 hrs after
bacterial injection and tissue samples of
liver, kidney, spleen, and lung were
collected for bacterial counts.
Main results: Compared with the control
group, ET-1 significantly impaired PMN
respiratory burst (p < .05) and prolonged
elimination of injected E. coli from the
blood (p < .01), whereas phagocytosis
functions remained unaltered. The
reduced PMN burst activity after ET-1
was associated with a higher bacterial
colonization of all organs (lung, p < .01;
spleen, p < .05). Endothelin-1 induced
increases in mean arterial pressure (p
< .01) and serum lactate concentrations,
whereas nitrite and nitrate levels
remained unaltered.
Conclusion: Endothelin-1 impairs 
respiratory burst and bacterial clearance 
from the blood and tissue. Thus, elevated 
levels of ET-1 during sepsis could induce 
organ hypoperfusion and cause 
disturbances in immune functions, 
increasing the risk of bacterial infections. 
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In spite of intensive research efforts 
and improved therapeutic strategies, the 
prevalence and mortality rate of sepsis in 
trauma patients remains high, thus pointing 
toward a reduced resistance against invasion 
of bacteria and their toxins into the 
circulation and colonization of different 
organs. In previous experiments, impairment 
of defense mechanisms, particularly of the 
bacterial clearance from the blood, were 
described after experimental activation of 
the coagulation system and the complement 
cascade (1), or after induction of hypoxia or 
hemorrhagic shock (2). Endothelin (ET)-1, a 
peptide with vasoconstrictive properties, 
was first described in 1988 by Yanagisawa 
et al. (3). In the last decade, various actions 
were found to be induced by ET-1, such as 
bronchoconstriction (4, 5), stimulation of 
leukocytes (6), and mitogenesis (7). Because 
elevated plasma concentrations have been 
detected during sepsis (8, 9), the role of ET-
1 as a mediator of septic complications is 
currently under investigation. Endothelin-1 
levels were elevated after endotoxin 
application (10) indicating the impact of ET-
1 in inflammatory diseases. Furthermore, 
ET-1 plays an important role as a mediator 
of granulocyte-mediated lung injury (11). 
However, it is not known whether ET-1 only 
affects vascular reactions (12, 13) or 
whether ET-1 also promotes the 
development of inflammatory diseases by 
influencing host defense mechanisms such 
as neutrophil (PMN) respiratory burst and 
phagocytosis activity or monocyte functions 
(14). To clarify the pathogenic role of ET-1 
in inflammatory diseases, the aim of this 
study was to examine the effects of ET-1 on 
PMN immune functions, bacterial killing 
capacity, and systemic blood pressure in 
anesthetized rabbits. To simulate bacterial 
invasion from various compartments, such 
as the gut, the urogenital tract, wounds, or 
implanted catheters into the circulating 
blood and to enable quantification of the 
clearing process, a defined number of 
exogenous Escherichia coli (108 colony-
forming units [CFU]) was injected 
intravenously 60 mins after starting the 
infusion of ET-1 (0.2 g/kg of body 
weight/min) or sodium chloride (control 
group). Respiratory burst activity and 
phagocytosis of granulocytes, as well as the 
elimination kinetics of exogenous E. coli 
and endotoxin (LPS) from the blood and the 
bacterial tissue distribution in the liver, 
spleen, kidney, and lung were studied. 
MATERIALS AND METHODS 
Animal Model. A total of 18 female 
chinchilla rabbits weighing between 2 and 3 
kg were anesthetized with ketamine 
(Ketanest; Parke Davis, Berlin, Germany, 50 
mg/kg body weight.) and xylazine (Rompun; 
Bayer, LeverKusen, Germany, 4 mg/kg 
body weight) and anticoagulated with 
heparin-sodium (1000 IU/kg body weight) 
injected into an ear vein catheter. The 
animals were placed in a supine position on 
a temperature-controlled (35 C [95 F]) 
operating table. After tracheostomy and 
intubation, the rabbits were mechanically 
ventilated with room air (tidal volume, 30 
mL; frequency, 30 cycles/min) via 
respiratory support (Servo 900D; Siemens 
Elema, Solna, Sweden) during the whole 
observation period. A polyvinyl chloride 
catheter (1.4 mm) was inserted into the right 
carotid artery for measurements of arterial 
blood pressure and for collection of blood 
samples. While monitoring the 
hemodynamic condition, anesthesia was 
maintained by injection of 5-10 mg/kg/hr 
ketamine and 0.5-1.5 mg/kg/hr xylazine. In 
addition to the basal fluid requirement of 3-4 
mL/kg body weight, blood loss from 
sampling was replaced by isovolemic 
injection of saline. 
Monitoring. After instrumentation of 
the rabbits, arterial and airway pressures 
were continuously monitored via Statham 
strain gauge transducers connected to a 
recorder (Sirecust 404A; Siemens). Blood 
samples were drawn intermittently for 
measurements of pH, PaO2, PaCO2, HCO3, 
hemoglobin, oxygen-saturation, and 
hematocrit (288 Blood Gas System, Ciba 
Corning, Fernwald, Germany), as well as of 
leukocyte and differential blood counts. The 
PMN burst and phagocytosis activity, serum 
lactate (test-combination lactate, fully 
enzymatic; Boehringer, Mannheim, 
Fernwald, Germany) and nitrite and nitrate 
(NOx) concentrations were determined 
according to the protocol. 
Bacterial Inoculum. An encapsulated, 
serum-resistant, nonhemolytic strain of E. 
coli (0111) with a smooth LPS phenotype, 
freshly isolated from blood of a septicemic 
patient, was cultured on blood agar plates. 
After 10 hrs of incubation at 37 C (98.6
F), the colonies were harvested and 
homogenized by vortexing in tryptic soy 
broth, adjusted to a density of 108 CFU/mL 
and frozen in aliquots at -70 C (-94 F) 
until use. The used amount of 108 CFU E. 
coli in the current study was based on pilot 
experiments providing a reproducible 
clearance rate and organ distribution without 
inducing severe hemodynamic changes that 
might influence clearance function by tissue 
hypoperfusion. In control group animals, the 
injection of 108 CFU E. coli was completely 
cleared from the circulation during the time 
period of 60 to 90 mins, thus allowing 
registration of acceleration or impairment of 
the clearance kinetics in the different 
experimental groups. 
Experimental Protocol. After a 30-
min period of stable hemodynamics, the 
animals were randomly assigned to one of 
two respective groups. Then, the first blood 
samples for baseline measurements were 
collected. 
Control Group (n = 9). After a 60-
min period during which saline was infused 
(0.1 mL/min), the standardized amount of E. 
coli (108 CFU suspended in 1 mL of tryptic 
soy broth) was injected into the ear vein 
catheter. For bacterial analysis, arterial 
blood was aseptically drawn at 1, 5, 15, 30, 
45, 60, 90, 120, 150, and 180 mins after 
bacterial injection. Blood gases, leukocyte 
counts, hematocrit, and hemoglobin 
concentrations were determined at 30-min 
intervals. Neutrophil oxidative burst and 
phagocytosis activity were determined 
before, and at 5, 30, 90, and 180 min after E. 
coli injection. At the end of the experiment 
the animals were killed with ketamine and 
xylazine. Subsequently, tissue samples of 
liver, spleen, kidney, and lung were 
removed under aseptic conditions for 
bacterial cultures. 
ET-1 group (n = 9). At 60 mins after 
onset of ET-1 infusion (0.2 g/kg/min) 
(Alexis, Läufelfingen, Switzerland), which 
was continued until the end of the 
observation period, 108 CFU E. coli were 
injected and the same protocol as in the 
control group was followed. Endothelin-1 
was dissolved in dimethylsulfoxide (Merck, 
Darmstadt, Germany) and adjusted to the 
final concentration with isotonic saline (pH 
6.95). 
The used dose of ET-1 was tested in 
dose-response studies in which the 
concentration of 0.2 g/kg body 
weight/min was able to induce a 
reproducible increase in arterial blood 
pressure, whereas higher concentrations of 
ET-1 killed the animals within 30 mins. 
Neutrophil Burst Activity. The 
amount of intracellular oxygen radical 
production was determined in freshly drawn 
heparinized whole blood. A test kit 
(Bursttest; Orpegen Pharma, Heidelberg, 
Germany) for the determination of the 
oxidative burst of leukocytes in whole blood 
was used. Single cell analysis was 
performed by flow cytometry. The method 
of the quantitative assay for monitoring the 
oxidative burst was previously described in 
detail (15). Two assays (100 L) of each 
sample were incubated (10 mins at 37 C 
[98.6 F]) with either phosphate-buffered 
saline (negative control), or with E. coli 
opsonized with antibodies and complement 
from pooled sera. Escherichia coli 
stimulates production of reactive oxygen 
intermediates. After the oxidation step 
(incubation with substrate 10 mins at 37 C 
[98.6 F]) in which the nonfluorescent 
substrate, dihydrorhodamine 123, was taken 
up by the phagocytes and converted during 
the respiratory burst to a green fluorescent 
compound (rhodamine 123), the whole 
blood was lysed and fixed. This oxidation is 
highly specific for the respiratory burst 
activity. To guarantee that no cell debris, 
dead cells, or bacteria would interfere with 
the measurement, DNA staining was 
performed with propidiumiodide (red 
fluorescence, FL-3). A quantity of 15,000 
cells of each sample was measured with a 
laser flow cytometer (FACS-can/Lysis II; 
Becton Dickinson, Heidelberg Germany) by 
using a blue-green excitation light (488-nm 
argon laser). The photomultiplier gain 
setting was adjusted to register all intensities 
of cellular fluorescence within the scale of 
256 channel resolution (4 decades). 
Neutrophils were identified by their 
characteristic size to granularity ratio. Only 
the selected cell population was considered 
for further analysis by using a multiple 
document interface for Windows 3.1 
(WinMDI 2.0; by J. Trotter, Scripps 
Research Institute, LaJolla, CA). During 
data acquisition, a "live" gate was set in the 
red fluorescence dot plot on those events 
that had at least the same DNA content as 
rabbit diploid cells. Only these cells were 
examined. For characterization of the 
fluorescence distribution, the mean channel 
fluorescence per cell was used, indicating 
the amount of rhodamine 123 per cell. 
Neutrophil Phagocytosis Activity. A 
test kit (Phagotest; Orpegen Pharma) for the 
determination of the phagocytic activity of 
leukocytes in whole blood was used. Single 
cell analysis was performed by flow 
cytometry. The method of the quantitative 
assay for investigating the phagocytic 
activity has been previously described in 
detail (16). Two assays of each sample (2  
100 L) were incubated with fluorescence 
isothiocyanate-marked opsonized E. coli 
either at 0 C (32 F) (control group) or at 
37 C (98.6 F) for 10 mins. Cells of the 
phagocytic system have receptors for a 
complement fragment 3b and for the 
constant part of the immunoglobulin 
molecule crystallizable fragment mediating 
the adhesion of the bacteria to the cell 
surface and subsequent engulfment. During 
the incubation period the fluorescence 
isothiocyanate-marked E. coli were ingested 
in the 37 C (98.6 F) assay. To exclude 
extracellular bacteria from measurement, 
they were quenched with a staining solution. 
The further steps, such as lysis, fixation, 
DNA-staining, and data acquisition by flow 
cytometer were performed in the same 
manner as in the burst-assay. The 
phagocytosis activity of leukocytes was 
determined by the content of fluorescence 
isothiocyanate-marked E. coli in the 
phagocytic cells, expressed as mean channel 
fluorescence per cell. 
Quantitative Microbiology 
Blood and tissue samples were 
chilled and assayed in duplicate after the end 
of the experiment. After incubation of the 
cultures at 37 C (98.6 F) for 24 hrs, the 
CFUs of E. coli were counted. The final 
bacterial concentration was calculated as the 
number of colonies per mL of blood, or as 
colonies per g of tissue, respectively. 
Blood Cultures. Blood samples were 
serially diluted in sterile saline. According 
to Sandys' technique (17), 100 L of whole 
blood and of each dilution step were plated 
onto cysteine lactose electrolyte-deficient 
agar plates. 
Organ Cultures. Aseptically 
collected organs, liver, spleen, lung, and 
kidney were weighed, and 0.8-2 g of each 
organ were homogenized (Ultra-Turrax, 
IKA-Werke, Staufen, Germany) in 3 mL of 
sterile saline. Serial dilutions of tissue 
suspension (100 L) were plated onto 
cysteine lactose electrolyte deficient agar 
plates. 
Detection of Endotoxin. To take into 
account plasma-related factors that interfere 
with limulus amebocyte lysate endotoxin 
reaction and considering the fact that each 
plasma sample has a different slope of the 
standard curve when spiked with endotoxin, 
an automated, kinetic, turbidimetric limulus 
amebocyte lysate microtiter test with 
individual internal standardization was used 
(18, 19). The principle is to establish an 
endotoxin reference curve in each sample by 
spiking the samples (diluted 1:5 and heated 
10 mins at 80 C [176 F]) with different 
LPS (NP3 Novo Pyrexal; Weidner, Waldorf, 
Germany) concentrations. After addition of 
lysate (Pyrotell; Associates of Cape Cod, 
Weidner, Waldorf, Germany) the increase in 
optical density was measured at 37 C 
(98.6 F) at 30-sec intervals for 100 mins at 
405 nm (Thermomax Photometer, 
Heidelberg, Germany). The deviation from 
the linear slope in the lower range of the 
spiked LPS represents the endogenous 
unknown endotoxin content of the sample. 
The sensitivity of this assay is 0.1 pg/mL. 
Measurement of Nitrite and Nitrate 
A commercially available 
colorimetric test kit was used for the 
determination of total NOx concentration in 
a two-step process (Cayman Chemicals, Ann 
Arbor, MI). In the first step, nitrate was 
converted into nitrite utilizing nitrate 
reductase. After that step, Griess reagent (20) 
that converts nitrite into a deep purple azo 
compound was added. Photometric 
measurement (AR 2001 photometer, Anthos 
Lab. Instruments, Krefeld, Germany) of the 
light absorption at 540 nm caused by this 
azo chromophore determines the NO2 
concentration. Azide, ascorbic acid, 
dithiothreitol, and mercaptoethanol interfere 
with the color development in 
concentrations of 100 M and 
phosphate >50 mmol interferes with the 
conversion of nitrite to nitrate. 
Histology 
Representative tissue samples of 
liver, lung, spleen, and kidney were frozen 
in liquid nitrogen. Then, they were cut into 
slices of 10 m for light microscopic 
examination. 
Statistical Analysis. Data are 
presented as the arithmetic mean  SEM. 
The logarithm of bacterial counts was used 
for statistical comparison. Differences 
between the two groups were tested by 
Student's t-test. Significance was accepted at 
p < .05. 
Experiments were performed in 
agreement with the commission for animal 
protection of the local government. The care 
and handling of animals were in accordance 
with the National Institutes of Health 
guidelines. 
RESULTS 
Respiratory Burst Activity of 
Neutrophil. Baseline values of respiratory 
burst activity, expressed as mean 
fluorescence intensity per cell (Fig. 1) and 
obtained before infusion of ET-1 (57  5), 
did not show any significant difference 
compared with the control group (49  12). 
The intensity of the burst reaction in the 
control group remained widely unaltered 
during the observation period, whereas ET-1 
induced a depression of the respiratory burst 
significant at 5, 90, and 180 mins (p < .05) 
after injection of E. coli. 
 
Figure 1. Respiratory burst activity as mean 
fluorescence intensity of rabbit granulocytes 
after infusion of 0.2 g kg-1 min-1 
endothelin-1 (solid bars) and control group 
(open bars). *p < .05 ET-1 vs. control group. 
Phagocytosis Activity of Neutrophil. 
Phagocytosis activity, expressed as mean 
fluorescence intensity per cell, before ET-1 
infusion did not differ significantly between 
the two groups (control group, 56  13 vs. 
ET-1 group, 76  23). It remained widely 
unchanged until the end of the observation 
period (control group, 46  12 vs. ET-1 
group, 66  24) without significant 
differences between the groups. 
Microbiological Results. In all groups, 
the blood cultures were found to be sterile 
before the injection of bacteria. In the 
control group, the number of bacteria 
decreased rapidly within 30 mins after 
bacterial injection. After 120 mins, bacteria 
were no longer detectable in the blood. The 
elimination of bacteria was markedly 
prolonged in the ET-1 group in which 
circulating bacteria were detectable until the 
end of the experiment (Fig. 2). Colony-
forming units in the blood were higher (p 
< .01) in the ET-1 group from 60 mins after 
the application of E. coli until the end of the 
experiments (27  14 CFU vs. sterile blood 
culture in the control group). After injection 
of E. coli, the delayed bacterial clearance 
from the circulation during ET-1 infusion 
was accompanied by a higher colonization 
in organs (Fig. 3). Tissue cultures from the 
control group showed the highest bacterial 
numbers in the liver (4.0  0.9  104 CFU) 
and the spleen (2.3  0.5  104 CFU). 
Lower counts were detected in the lung (750 
 120 CFU) and the kidney (360  150 
CFU). In contrast to this, ET-1 infusion 
resulted in an altered organ distribution 
pattern with highest amounts of E. coli in 
the spleen (1.4  0.5  105 CFU), 
followed by the liver (7.4  2.8  104 
CFU), the lung (3.6  0.5  103 CFU), and 
the kidney (760  320 CFU). Significant 
statistical differences in bacterial counts 
were found in the spleen (p < .05) and the 
lung (p < .01) compared with the control 
group. 
 
Figure 2. Elimination of Escherichia coli 
from blood of control group (circles) and 
after infusion of 0.2 g kg-1 min-1 
endothelin-1 (triangles). Mean counts of 
colony-forming units (CFU)/mL are plotted 
semilogarithmically against time in minutes. 
**p < .01 ET-1 group vs. control group. 
 
Figure 3. Bacterial counts per gram in 
different organs at 3 hrs after injection of 
108 colony-forming units (CFU) of 
Escherichia coli in control group (open bars) 
and during infusion of 0.2 g kg-1 min-1 
endothelin-1 (solid bars). Liver and spleen, 
left; lung and kidney, right. *p < .05. **p 
< .01 ET-1 group vs. control group. 
Lipopolysaccharide Clearance. To 
determine the concentration of endotoxin 
injected with the E. coli suspension and to 
study the clearance rate during the infusion 
of ET-1, LPS levels were measured before 
the injection of E. coli, and at 30, 60, 120, 
and 180 mins. No endotoxin was detectable 
before injection of bacteria in any group. In 
the control and the ET-1 groups, endotoxin 
levels continuously decreased after bacterial 
injection until the end of the experiment, in 
the control group from 200  23 to 40  
15 ng/mL and in the ET-1 group from 211 
 21 to 25  14 ng/mL. 
Nitrite and Nitrate 
Nitrite and nitrate levels as an 
indicator for ET-1-induced, NO-synthesis 
activity were measured before and during 
ET-1 infusion. Baseline values of NOx were 
similar in both groups (control group 18  
3 mol/L; ET-1 18  3 mol/L). Until 
the end of the observation period, no major 
changes were detectable within or between 
the groups (control group 20  3 mol/L; 
ET-1 17  3 mol/L). 
Hemodynamic and Metabolic 
Variables. In the control group, mean 
arterial blood pressure, hemoglobin, 
hematocrit, and blood gases (PaO2, PaCO2, 
SaO2, pH) remained within 10% of 0 values 
during the observation period. Baseline 
values of mean arterial pressure (MAP) were 
comparable in both groups (55  3 vs. 55 
 4 mm Hg in the control and ET-1 groups, 
respectively). A sustained increase in MAP 
was registered after the onset of the ET-1 
infusion (Fig. 4) and compared with the 
control group, significant elevations were 
reached from -15 to 15 mins (p < .05) until 
the end of the observation period (p < .01). 
E. coli injection (0 min) induced a transient 
pressure increase of ~10 mm Hg in both 
groups. Mean arterial pressure decreased 
progressively in the control group to 40  2 
mm Hg at the end of the observation period. 
In the ET-1 group, MAP reached maximum 
values immediately after the injection of E. 
coli (79  5 mm Hg). Until the end of the 
experiment, a decrease in arterial pressure to 
final values of 50  3 mm Hg was observed 
but MAP remained significantly higher in 
the ET-1 group than in the control group. 
 
Figure 4. Mean arterial blood pressure 
(MAP) in rabbits treated with 0.2 g kg-1
min-1 endothelin-1 (triangles) and in sodium 
chloride-treated control group (circles). At 
time point 0 min 108 colony-forming units E. 
coli were injected (*p < .05; **p < .01). 
There was a continuous increase in 
serum lactate concentrations in both groups 
more pronounced in the ET-1 group with a 
four-fold increase from 60 mins (0.4  0.1 
mmol/L) until the end of the experiments 
(1.4  0.1 mmol/L; p < .01 vs. the control 
group). Minimal changes in hemoglobin and 
hematocrit, comparable in all groups, ensued 
from dilution effects caused by blood 
sampling and isovolemic substitution with 
saline. 
White Blood Cell Counts. A decrease 
in granulocyte counts in the circulating 
blood has also been observed in both groups. 
Granulocyte counts were comparable in both 
groups at the beginning of the experiments 
(3.6  0.7  103 cells/ L in the control 
group and 3.7  0.5  103 cells/ L in the 
ET-1 group). At 150 mins thereafter, 
significant lower counts of granulocytes 
were found in the ET-1 group as compared 
with untreated control group (0.9  0.3  
103 cells/ L in the control group vs. 0.3  
0.1  103 cells/ L in the ET-1 group; p 
< .05). 
Histology. In contrast to the control 
group, signs of hypoperfusion in liver, such 
as hydropic swelling of cells and the loss of 
nuclei, were observed by light microscopy 
of organ slices in the ET-1 group. 
Furthermore, a perisinusoidal infiltration 
was observed. Regarding the morphology of 
the other organs, no major differences were 
found between the ET-1 and the control 
group. 
DISCUSSION 
The activation of immunocompetent 
cells, particularly in mononuclear 
phagocytes and neutrophils, plays a key role 
in the sequel of inflammatory reactions. 
Under physiologic conditions, these 
reactions serve to eliminate invading 
microorganisms via phagocytosis and killing 
by toxic oxygen radicals and proteases. 
Nosocomial infections are the most common 
complications in intensive care units, 
leading to acute respiratory distress 
syndrome or multiple organ failure (21). In 
view of therapeutic strategies, many studies 
have been performed to describe the 
relationship between critical illness and the 
enhanced predisposition of the organism for 
microbial invasion. A link between shock 
and development of bacteremia and 
endotoxemia has often been reported (22, 
23). In animal models, a shock-induced 
immune suppression has been demonstrated 
(2, 24). Also, induction of a hemorrhagic 
shock resulted in an impaired inflammatory 
response (25) and a reduced peritoneal 
bacterial clearance (26). Because the gut has 
been identified as a source of bacteremia, 
intestinal hypoperfusion was found to be 
related to the loss of intestinal barrier 
function and bacterial translocation into 
other organs (27). Increased ET-1 levels 
have often been reported after endotoxin 
exposure (10) or in sepsis (8). Although 
vascular reactions caused by the release of 
ET-1 are well documented (28), less is 
known about the effects of ET-1 on host 
defense mechanisms. Therefore, we 
designed this study to evaluate the potential 
influence of ET-1 on neutrophil functions 
and bacterial clearance and to determine the 
role of ET-1 in mediating septic 
complications. This study did not investigate 
altered translocation from the gut, but rather, 
whether host defense mechanisms are 
impaired after infusion of ET-1. The 
injection of E. coli was chosen as a correlate 
of bacterial invasion from various 
compartments, e.g., the gut, the urogenital 
tract, wounds, or catheters into the 
circulation. 
Compared with the control group, 
treatment with ET-1 reduced neutrophil 
respiratory burst activity and delayed 
bacterial elimination from the blood. 
Differences in PMN burst activity between 
the control group and the ET-1 group occur 
after onset of ET-1 infusion reaching 
significance 5 mins after E. coli injection 
(Fig. 1). Conflicting results have been 
obtained concerning the ability of ET-1 to 
activate leukocytes. Although some 
investigators described the neutrophil-
activating properties of ET-1 (6), others 
reported unchanged activation levels (29) or 
even inhibition of leukocyte endothelium 
interactions (30). The elimination of bacteria 
from the blood is a multifactorial process. 
After chemotaxis, adherence, and 
phagocytosis, bacterial killing is finally 
achieved by respiratory burst. Thus, 
disturbance of one of the mechanisms is 
capable of interrupting the bactericidal 
capacity of the blood. The observed 
suppression of oxidative burst might be a 
correlate of the impaired bacterial clearance 
in blood and tissues. The reduced burst 
activity, however, was paralleled by an 
unaffected PMN phagocytosis activity. One 
can only speculate whether the reduced burst 
activity limits the killing of phagotized 
bacteria. This hypothesis is supported by our 
data of reduced burst activity during ET-1 
infusion associated with an impaired 
bacterial elimination from blood and organs. 
During further observation, after a delayed 
elimination of E. coli, the number of 
injected E. coli (Fig. 2) decreased rapidly in 
the blood within the first 15 mins in both 
groups. Furthermore, significantly higher 
tissue colonization was found in lung and 
spleen tissue in the ET-1 group. 
Few data exist concerning depressive 
effects of ET-1 on immune functions. Some 
investigators (31, 32) described a significant 
neutropenia after ET-1 infusion. Other 
groups (6) found that ET-1 induces PMN 
migration into vessel wall and subsequent 
elastase release, thereby causing tissue 
injury. Moreover, monocytic release of 
tumor necrosis factor  has been 
demonstrated after ET-1 (33, 34). Tumor 
necrosis factor  is known to impair 
bacterial clearance leading to enhanced 
organ colonization (24). The described 
actions of ET-1 may contribute to a reduced 
bacterial killing and to an increased vascular 
permeability. 
Because ET-1 has been reported to 
release nitric oxide (NO) from the 
endothelium (35), NOx levels have been 
measured in the current study. No changes, 
however, were observed. Thus changes in 
MAP are not attributable to a modulation of 
extracellular measurable NO. Nevertheless, 
intracellular levels of NO, which also could 
affect vascular tone, were not investigated in 
the current study. Considerations in how far 
the observed ET-1-induced vasoconstriction 
(Fig. 4) contributes to the observed 
immunologic effects, remain speculative. 
Enhanced vascular resistance after ET-1 
application has been found in the systemic 
circulation (36), as well as in kidneys (37), 
lungs (38), and intestines (39). In a 
previously published study (40), we 
investigated the effects of norepinephrine in 
our model and observed delayed bacterial 
elimination from the circulation. Thus, 
hypoperfusion and subsequent tissue 
hypoxia, reflected by the observed increase 
in lactate concentrations and the hydropic 
cell swelling in the liver, might contribute to 
decreased cellular bacterial killing. Altered 
immune functions resulting from ET-1 on 
cellular levels have been described (6, 29-
32), but conclusions concerning the effects 
on host defense have not been drawn. 
Endothelin-1-induced effects on immune 
functions, however, seem to be 
multifactorial. On the one hand, the 
attenuation of neutrophil respiratory burst, 
and on the other hand, hemodynamic effects 
resulting from vasoconstriction, followed by 
hypoperfusion and subsequent tissue 
hypoxia, may be responsible for the 
observed impairment of bacterial killing. 
In summary of our results, ET-1 
impairs respiratory burst and bacterial 
clearance from the blood and tissue. Thus, 
elevated levels of ET-1 during sepsis could 
contribute to disturbances in immune 
functions, increasing the risk of bacterial 
infections. Our results indicate the crucial 
role of ET-1, not only as a regulator of 
vascular tone, but also as an important 
mediator affecting immune functions. 
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